$750 | Single User
$1500 | Site License
$2250 | Enterprise License

Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update
[Report Updated: 18-05-2017]

Published by Global Data: 18 May 2017 | 82314 | In Stock
Related Topics: Abbott , Vascular

Introduction

Summary

Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires, and others. Abbott Vascular’s peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals. Abbott Vascular is headquartered in Santa Clara, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Abbott Vascular Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update [Report Updated: 18-05-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Abbott Vascular Inc Company Overview 6

    Abbott Vascular Inc Company Snapshot 6

    Abbott Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 6

    Abbott Vascular Inc – Pipeline Analysis Overview 9

    Abbott Vascular Inc - Key Facts 9

    Abbott Vascular Inc - Major Products and Services 10

    Abbott Vascular Inc Pipeline Products by Development Stage 11

    Abbott Vascular Inc Ongoing Clinical Trials by Trial Status 13

    Abbott Vascular Inc Pipeline Products Overview 17

    Absorb GT1 Bioresorbable Vascular Scaffold 17

    Absorb GT1 Bioresorbable Vascular Scaffold Product Overview 17

    Absorb GT1 Bioresorbable Vascular Scaffold Clinical Trial 18

    Chemical RDN System 31

    Chemical RDN System Product Overview 31

    Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) 32

    Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Product Overview 32

    ESPRIT Bioresorbable Vascular Scaffold 33

    ESPRIT Bioresorbable Vascular Scaffold Product Overview 33

    Next Generation SUPERA Delivery System 34

    Next Generation SUPERA Delivery System Product Overview 34

    Second Generation Bioresorbable Vascular Scaffold 35

    Second Generation Bioresorbable Vascular Scaffold Product Overview 35

    Tendyne Bioprosthetic Mitral Valve Implantation System 36

    Tendyne Bioprosthetic Mitral Valve Implantation System Product Overview 36

    Tendyne Bioprosthetic Mitral Valve Implantation System Clinical Trial 37

    Xience SBA Everolimus Eluting Coronary Stent System 38

    Xience SBA Everolimus Eluting Coronary Stent System Product Overview 38

    XIENCE Thinman DES 39

    XIENCE Thinman DES Product Overview 39

    ZoMaxx Drug Eluting Coronary Stent System 40

    ZoMaxx Drug Eluting Coronary Stent System Product Overview 40

    Abbott Vascular Inc - Key Competitors 41

    Abbott Vascular Inc - Key Employees 42

    Abbott Vascular Inc - Locations And Subsidiaries 43

    Head Office 43

    Recent Developments 44

    Abbott Vascular Inc, Recent Developments 44

    May 12, 2017: Abbott Initiates Voluntarily Recall of NC Tenku RX PTCA Balloon Catheter 44

    May 12, 2017: Abbott Initiates Voluntarily Recall of NC Traveler Coronary Dilatation Catheter 44

    May 12, 2017: Abbott Initiates Voluntarily Recall of Specific Lots of NC Trek RX Coronary Dilatation Catheter 44

    May 02, 2017: TGA Hazard Alert On Absorb Bioresorbable Vascular Scaffold System 45

    Mar 27, 2017: Abbott Vascular Provides Update On Absorb Bioresorbable Vascular Scaffold 45

    Mar 18, 2017: Absorb GT1 Bioresorbable Vascular Scaffold by Abbott Vascular: Letter to Health Care Providers - FDA Investigating Increased Rate of Major Adverse Cardiac Events 45

    Mar 18, 2017: Late-Breaking Data on Abbott's MitraClip System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease 46

    Feb 21, 2017: Ascension Michigan Leads State in Pioneering Dissolving Heart Stent 47

    Feb 17, 2017: Absorbable Stents Offer Alternative for Wake Forest Baptist Cardiology Patients 47

    Nov 07, 2016: Abbott's Absorb Bioresorbable Stent Approved as the First Fully Dissolving Heart Stent in Japan 48

    Appendix 50

    Methodology 50

    About GlobalData 52

    Contact Us 52

    Disclaimer 52

List Of Tables
in Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update [Report Updated: 18-05-2017]

List of Tables

Abbott Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Abbott Vascular Inc Pipeline Products by Equipment Type 7

Abbott Vascular Inc Pipeline Products by Indication 8

Abbott Vascular Inc Ongoing Clinical Trials by Trial Status 8

Abbott Vascular Inc, Key Facts 9

Abbott Vascular Inc, Major Products and Services 10

Abbott Vascular Inc Number of Pipeline Products by Development Stage 11

Abbott Vascular Inc Pipeline Products Summary by Development Stage 12

Abbott Vascular Inc Ongoing Clinical Trials by Trial Status 13

Abbott Vascular Inc Ongoing Clinical Trials Summary 14

Absorb GT1 Bioresorbable Vascular Scaffold - Product Status 17

Absorb GT1 Bioresorbable Vascular Scaffold - Product Description 17

Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects with de Novo Native Coronary Artery Lesions in Chinese Population 18

Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold In the Treatment of Subjects with De Novo Native Coronary Artery Lesions 18

Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions 18

Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System (BVS EECSS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions 19

Absorb GT1 Bioresorbable Vascular Scaffold - A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions: ABSORB EXTEND Clinical Investigation 19

Absorb GT1 Bioresorbable Vascular Scaffold - A Multicenter Prospective Natural History Study Using Multimodality Imaging in Patients with Acute Coronary Syndromes - PROSPECT II (Natural History Study), Combined with a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial) 20

Absorb GT1 Bioresorbable Vascular Scaffold - A Prospective Evaluation of a Standardized Strategy for the Use of Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Registry 20

Absorb GT1 Bioresorbable Vascular Scaffold - A Prospective, Randomized Trial of Synergy Bioresorbable Polymer Coated Stents Versus Absorb Bioresorbable Backbone Stents in Patients Undergoing Coronary Stenting (ISAR-RESORB) 21

Absorb GT1 Bioresorbable Vascular Scaffold - A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold versus Everolimus-eluting Metallic Stent in Long Coronary Lesions 21

Absorb GT1 Bioresorbable Vascular Scaffold - A Randomized Trial of the Treatment of Non- Culprit Lesion After STEMI: Bioresorbable Vascular Scaffold Versus Optimal Medical Therapy (NCL Study) 21

Absorb GT1 Bioresorbable Vascular Scaffold - ABSORB Bioresorbable Scaffold versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis 22

Absorb GT1 Bioresorbable Vascular Scaffold - ABSORB III RCT Pharmacokinetics (PK) Sub-study 22

Absorb GT1 Bioresorbable Vascular Scaffold - ABSORB Post-approval Clinical Study 22

Absorb GT1 Bioresorbable Vascular Scaffold - Amsterdam Investigator-initiated Absorb Strategy All-comers Trial (AIDA Trial) - A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold Strategy Versus the XIENCE Family (XIENCE PRIME or XIENCE Xpedition) Everolimus Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-comers 23

Absorb GT1 Bioresorbable Vascular Scaffold - Bifurcation ABSORB OCT Trial 23

Absorb GT1 Bioresorbable Vascular Scaffold - Bioresorbable Vascular Stents for Treatment of Coronary Bifurcation Lesions Assessed by Optical Coherence Tomography - The BIFSORB Study 24

Absorb GT1 Bioresorbable Vascular Scaffold - Clinical Study on Absorb Polylactic, Reabsorbable Coronary Scaffold (RAI) 24

Absorb GT1 Bioresorbable Vascular Scaffold - Comparison of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold System with a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial Infarction 24

Absorb GT1 Bioresorbable Vascular Scaffold - Complex Bifurcation Lesions - A Randomized Comparison Between the AXXESS Device in Combination with Absorb BVS, and Modified T Stenting with Absorb BVS: An OCT Study 25

Absorb GT1 Bioresorbable Vascular Scaffold - Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms - A Multi-modality, Multi-specialty Collaborative Study (PERFECT Program) 25

Absorb GT1 Bioresorbable Vascular Scaffold - Dissection Re-entry Evaluation with Absorb Bioresorbable Vascular Scaffolds in Chronic Total Occlusion - The Discrete CTO Study 26

Absorb GT1 Bioresorbable Vascular Scaffold - Evaluation of Microcirculatory Protection in Percutaneous Revascularisation with Bioresorbable Vascular Scaffolds Versus Metallic Drug-eluting Stents: A Device- and Implant Technique-based Comparison 26

Absorb GT1 Bioresorbable Vascular Scaffold - Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease 27

Absorb GT1 Bioresorbable Vascular Scaffold - Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study 27

Absorb GT1 Bioresorbable Vascular Scaffold - German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold System in Patients with Coronary Artery Stenosis 28

Absorb GT1 Bioresorbable Vascular Scaffold - Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion: A Randomized H215O PET/CT Study 28

Absorb GT1 Bioresorbable Vascular Scaffold - Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI) 28

Absorb GT1 Bioresorbable Vascular Scaffold - Prospective Study of Bioresorbable Vascular Scaffold Treatment with Scoring Balloon Pre-dilatation in Patients with In-stent Restenosis 29

Absorb GT1 Bioresorbable Vascular Scaffold - Real World Advanced Experience of Bioresorbable Scaffold by Smart Angioplasty Research Team (SMART REWARD) 29

Absorb GT1 Bioresorbable Vascular Scaffold - Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients with Internal Pudendal Artery-related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB) 30

Absorb GT1 Bioresorbable Vascular Scaffold - Strut Coverage with SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction: An Intracoronary Optical Coherence Tomography Randomized Study 30

Chemical RDN System - Product Status 31

Chemical RDN System - Product Description 31

Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status 32

Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description 32

ESPRIT Bioresorbable Vascular Scaffold - Product Status 33

ESPRIT Bioresorbable Vascular Scaffold - Product Description 33

Next Generation SUPERA Delivery System - Product Status 34

Next Generation SUPERA Delivery System - Product Description 34

Second Generation Bioresorbable Vascular Scaffold - Product Status 35

Second Generation Bioresorbable Vascular Scaffold - Product Description 35

Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status 36

Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description 36

Tendyne Bioprosthetic Mitral Valve Implantation System - Early Feasibility Study of the Tendyne Mitral Valve System 37

Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Efficacy of Tendyne Bioprosthetic Mitral Valve System in Subjects with Symptomatic Mitral Regurgitation of Degenerative or Functional Etiology 37

Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Performance of the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) in Inoperable Subjects with Mitral Regurgitation (MR) 37

Xience SBA Everolimus Eluting Coronary Stent System - Product Status 38

Xience SBA Everolimus Eluting Coronary Stent System - Product Description 38

XIENCE Thinman DES - Product Status 39

XIENCE Thinman DES - Product Description 39

ZoMaxx Drug Eluting Coronary Stent System - Product Status 40

ZoMaxx Drug Eluting Coronary Stent System - Product Description 40

Abbott Vascular Inc, Key Employees 42

Glossary 51

List Of Figures, Charts and Diagrams
in Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update [Report Updated: 18-05-2017]

List of Figures

Abbott Vascular Inc Pipeline Products by Equipment Type 7

Abbott Vascular Inc Pipeline Products by Development Stage 11

Abbott Vascular Inc Ongoing Clinical Trials by Trial Status 13

Additional Details

Publisher

Global Data

Publisher Information

Reference

82314 | GDME6037PD

Number of Pages

53

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Abbott Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update
SummaryAbbott Vascular Inc. (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Labor...
30 Mar 2016 by Global Data USD $750 More Info
Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
09 Mar 2016 by Global Data USD $250 More Info
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth st...
07 Mar 2016 by Global Data USD $125 More Info
Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
24 Feb 2016 by Global Data USD $250 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC), formerly TheraSense, Inc. a subsidiary of Abbott Laboratori...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical di...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into t...
11 Jan 2016 by Global Data USD $125 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC)formerly known as TheraSense, Inc., discovers, develops, manu...
15 Oct 2015 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott) is a medical diagnostic company. The company provides molecula...
15 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update [Report Updated: 18-05-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)